Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Vasopressin Versus Norepinephrine for the Management of Septic Shock in Cancer Patients (VANCS II)

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
Cristiane Maciel Zambolim, Instituto do Cancer do Estado de São Paulo
ClinicalTrials.gov Identifier:
NCT01718613
First received: October 29, 2012
Last updated: May 18, 2015
Last verified: May 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: December 2015
  Primary Completion Date: March 2014 (Final data collection date for primary outcome measure)